Sachdev Amit (CIK 1406338) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell VRTX (1,518 shares), Sell VRTX (1,846 shares), Buy VRTX (23,479 shares), Buy VRTX (25,026 shares), Sell VRTX (920 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 1,518 | $736,397 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 1,846 | $897,802 |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 23,479 | $3.7M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 25,026 | $4.7M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 920 | $426,797 |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 2,730 | $1.3M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 1,848 | $860,798 |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 10,263 | $4.8M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 19,662 | $9.2M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 7,241 | $3.4M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 11,712 | $5.5M |
| 2026-02-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 4,237 | $2.0M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 5,789 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 2,140 | $1.0M |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 3,548 | $1.7M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 2,057 | $963,519 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 7,866 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 3,883 | $0 |
| 2025-02-28 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 3,703 | $1.8M |
| 2025-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 2,470 | $1.2M |
| 2025-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 2,139 | $991,341 |
| 2025-02-14 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 6,211 | $0 |
| 2025-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Sell | 2,056 | $962,167 |
| 2025-02-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 8,210 | $0 |
| 2025-02-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP Chief Patient & Ext Af Off | Buy | 7,114 | $0 |
Source: SEC Form 4 filings · as of 2026-02-26